SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-027657
Filing Date
2014-04-15
Accepted
2014-04-15 18:23:05
Documents
1
Period of Report
2013-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3584
  Complete submission text file 0001209191-14-027657.txt   5078
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address 6042 CORNERSTONE CT. WEST, SUITE B SAN DIEGO CA 92121
Business Address
Miao Zhenwei (Reporting) CIK: 0001605519 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36150 | Film No.: 14766135